Bajaj Healthcare · NSE: BAJAJHCARE · BSE: 539872
Q2 FY21 results · Jul–Sep 2020
Bajaj Healthcare reported revenue from operations of ₹206.63 crore (up 105.5% from Q2 FY20) and net profit of ₹20.12 crore (up 513.8% from Q2 FY20) for Q2 FY21 (Jul–Sep 2020), on a standalone basis.
| Item | Q2 FY21 | Q2 FY20 | YoY | Q1 FY21 | QoQ |
|---|---|---|---|---|---|
| Revenue from operations | 206.63 | 100.55 | +105.5% | 139.83 | +47.8% |
| Other income | 2.09 | — | — | 0.90 | +132.3% |
| Total income | 208.73 | — | — | 140.73 | +48.3% |
| Profit before tax | 28.26 | 4.59 | +515.6% | 20.43 | +38.3% |
| Net profit for the period | 20.12 | 3.28 | +513.8% | 15.29 | +31.6% |
| EPS, basic (₹) | 14.58 | 2.38 | +512.6% | 11.08 | +31.6% |
| Net margin (%) | 9.7 | 3.3 | 10.9 |
Standalone
- Filed with BSE
- 03 Nov 2020, 14:54 IST
- Board meeting
- 29 Oct 2020
- Period
- 01 Jul 2020 to 30 Sep 2020
- Review status
- Unaudited
- Source
- XBRL filing on BSE